Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Pure-Heart-1: A P2X7R Single Nucleotide Mutation Promotes Chronic Allograft Vasculopathy

NCT02082821 is registered in ClinicalTrials.gov with Boston Children's Hospital as lead sponsor.

NCT NCT02082821
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02082821 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Pure-Heart-1: A P2X7R Single Nucleotide Mutation Promotes Chronic Allograft Vasculopathy
Lead sponsor
Boston Children's Hospital
Phase
Observational
Overall status
Completed
Start date
January 31, 2014
Completion date
December 31, 2020
Enrollment
200 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

cardiac allograft vasculopathy